Billings Clinic
Especially For:

Clinical Trials

Title   GI-Colorectal Cancer Metastatic-First Line
Description   CTSU CALGB 80405-A Phase III Trial of Irinotecan/5-FU Leucovorin or Oxaliplatin + 5-FU/Leucovorin with Bevacizumab, or Cetuximab or with The Combination for Patients with Untreated Metastatic Adenocarcinoma of The Colon or Rectum.
IRB Number   CTSU CALGB 80405
Category   Gastrointestinal
Inclusion/Notes   Physician choice of FOLFOX or FOLFIRI with Bevacizumab, randomized to get with/without Cetuximab.
Must send tissue for KRAS testing.

Please contact Tricia Montgomery, RN for additional inclusion/exclusion criteria.
Status   Active
Start Date   12/09/2005
Principal Investigator (PI)   Robert Geller, MD
Contact Name   Tricia Montgomery RN BSN
Contact Email
Phone   (406) 435-7483
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.